Xiaowei Xi

566 total citations
19 papers, 419 citations indexed

About

Xiaowei Xi is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xiaowei Xi has authored 19 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Xiaowei Xi's work include Cancer-related molecular mechanisms research (9 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xiaowei Xi is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xiaowei Xi collaborates with scholars based in China and Germany. Xiaowei Xi's co-authors include Zhenbo Zhang, Youji Feng, Dongmei Zhou, Yan Qin, Hong Liao, Xiaomei Wu, Qianqian Wang, Ting Lei, Xiang Tao and Yongjuan Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Xiaowei Xi

19 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowei Xi China 13 296 204 82 52 42 19 419
Ashley N. Kamimae-Lanning United States 7 317 1.1× 88 0.4× 53 0.6× 59 1.1× 34 0.8× 8 415
Marianna Buttarelli Italy 13 179 0.6× 88 0.4× 129 1.6× 38 0.7× 41 1.0× 19 320
Stacy Hultine United States 5 308 1.0× 278 1.4× 74 0.9× 47 0.9× 21 0.5× 6 414
Shilong Fu China 12 207 0.7× 217 1.1× 56 0.7× 56 1.1× 22 0.5× 20 350
Hsin‐Yi Lan Taiwan 5 236 0.8× 167 0.8× 219 2.7× 90 1.7× 22 0.5× 6 463
Markéta Bednaříková Czechia 8 564 1.9× 538 2.6× 74 0.9× 27 0.5× 26 0.6× 20 751
Hui-Zi Chen United States 4 277 0.9× 96 0.5× 144 1.8× 31 0.6× 32 0.8× 5 363
Yong–Jig Cho United States 8 276 0.9× 89 0.4× 167 2.0× 26 0.5× 48 1.1× 14 390
Ke Cao China 11 448 1.5× 465 2.3× 54 0.7× 44 0.8× 13 0.3× 11 577

Countries citing papers authored by Xiaowei Xi

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Xi more than expected).

Fields of papers citing papers by Xiaowei Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Xi. The network helps show where Xiaowei Xi may publish in the future.

Co-authorship network of co-authors of Xiaowei Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Xi. A scholar is included among the top collaborators of Xiaowei Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Xi. Xiaowei Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Xi, Xiaowei, et al.. (2024). CD8+ T cell exhaustion in the tumor microenvironment of breast cancer. Frontiers in Immunology. 15. 1507283–1507283. 40 indexed citations
2.
Xi, Xiaowei, et al.. (2024). MCT1 gene silencing enhances the immune effect of dendritic cells on cervical cancer cells. Advances in Clinical and Experimental Medicine. 33(7). 739–749. 4 indexed citations
3.
Liu, Xianqiang, Xiaowei Xi, Shengshan Xu, et al.. (2024). Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer. Frontiers in Immunology. 15. 1507501–1507501. 26 indexed citations
4.
Yang, Shimin, Yifan Luo, Dongmei Zhou, Jiangdong Xiang, & Xiaowei Xi. (2023). RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer. Translational Cancer Research. 12(10). 2556–2571. 4 indexed citations
5.
Wang, Chong, et al.. (2023). Identification and validation of m5c-related lncRNA risk model for ovarian cancer. Journal of Ovarian Research. 16(1). 6 indexed citations
6.
7.
Wu, Xiaomei, et al.. (2021). Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer. BioMed Research International. 2021(1). 6622439–6622439. 12 indexed citations
8.
Xi, Xiaowei, et al.. (2020). LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis. Biochemical and Biophysical Research Communications. 533(4). 1088–1094. 21 indexed citations
9.
Zhang, Liming, et al.. (2020). Expression of immune cell markers and tumor markers in patients with cervical cancer. International Journal of Gynecological Cancer. 30(7). 969–974. 8 indexed citations
10.
Zhang, Jing, Wenxue Liu, Xiaoling Ma, et al.. (2018). The activation of microRNA-520h–associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression. Cell Death and Disease. 9(9). 884–884. 29 indexed citations
11.
Zhuang, Yan, Jiangdong Xiang, Wei Bao, et al.. (2017). MDH2 Stimulated by Estrogen-GPR30 Pathway Down-Regulated PTEN Expression Promoting the Proliferation and Invasion of Cells in Endometrial Cancer. Translational Oncology. 10(2). 203–210. 15 indexed citations
12.
Yang, Xiaoming, Dandan Xia, Lei Liu, et al.. (2017). Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis. Cellular Physiology and Biochemistry. 42(1). 185–197. 16 indexed citations
13.
Xie, Bingying, Qiaoying Lv, Chengcheng Ning, et al.. (2016). TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation. Biochemical and Biophysical Research Communications. 482(4). 857–862. 21 indexed citations
14.
Qin, Yan, Fangyuan Wang, Yi Miao, et al.. (2016). Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase. Tumor Biology. 37(9). 12263–12271. 16 indexed citations
15.
Zhang, Jing, Lei Liu, Yunyan Sun, et al.. (2016). MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression. Oncotarget. 7(18). 26516–26534. 25 indexed citations
16.
Bai, Mingzhu, Mu Yuan, Hong Liao, et al.. (2015). OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma. Oncology Reports. 33(4). 1745–1752. 32 indexed citations
17.
Wu, Xiaomei, Xiaowei Xi, Yan Qin, et al.. (2013). MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition. Medical Oncology. 30(4). 751–751. 45 indexed citations
18.
Zhang, Zhenbo, Dongmei Zhou, Yunli Lai, et al.. (2012). Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways. Cancer Letters. 319(1). 89–97. 92 indexed citations
19.
Wan, Xiaoping, Bin Cai, Ling Liu, Xiaowei Xi, & Yixia Yang. (2006). [Study of differential gene expression in different stage human endometrial cancer].. PubMed. 41(1). 38–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley N. Kamimae-Lanning Breakdown of academic impact, for papers by Marianna Buttarelli Breakdown of academic impact, for papers by Stacy Hultine Breakdown of academic impact, for papers by Shilong Fu Breakdown of academic impact, for papers by Hsin‐Yi Lan Breakdown of academic impact, for papers by Markéta Bednaříková Breakdown of academic impact, for papers by Hui-Zi Chen Breakdown of academic impact, for papers by Yong–Jig Cho Breakdown of academic impact, for papers by Ke Cao
Rankless by CCL
2026